Sunday - May 5, 2024
Buffalo Clinical Trial Contributed to FDA Approval for Fast-Acting Insulin for Children
January 22, 2020
BUFFALO, New York, Jan. 22 -- The State University of New York Buffalo campus issued the following news release:

* * *

- Researchers say the success of these collaborations proves the power of UB's academic health center

The approval on Dec. 19, 2019 by the Food and Drug Administration of a fast-acting insulin for children with diabetes mellitus came about with the help of researchers and providers at the University at Buffalo, UBMD Pediatrics and Oishei Ch . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products